• LOGIN
    Login with username and password
Repository logo

BORIS Portal

Bern Open Repository and Information System

  • Publications
  • Theses
  • Research Data
  • Projects
  • Organizations
  • Researchers
  • More
  • Collections
  • Statistics
  • LOGIN
    Login with username and password
Repository logo
Unibern.ch
  1. Home
  2. Publications
  3. Long-term risk of major bleeding after discontinuing anticoagulation for unprovoked venous thromboembolism: a systematic review and meta-analysis.

Long-term risk of major bleeding after discontinuing anticoagulation for unprovoked venous thromboembolism: a systematic review and meta-analysis.

Details
Files
DOI
10.48350/162451
Publisher DOI
10.1055/a-1690-8728
PubMed ID
34753191
Abstract
BACKGROUND

The long-term risk of major bleeding after discontinuing anticoagulant therapy for a first unprovoked venous thromboembolism (VTE) is uncertain.

OBJECTIVES

To determine the incidence of major bleeding up to 5 years after discontinuing anticoagulation for a first unprovoked VTE.

METHODS

We searched MEDLINE, EMBASE, and Cochrane CENTRAL (from inception to January 2021) to identify relevant randomized controlled trials (RCTs) and prospective cohort studies reporting major bleeding after discontinuing anticoagulation in patients with a first unprovoked VTE who had completed ≥3 months of initial treatment. Unpublished data on major bleeding events and person-years were obtained from authors of included studies to calculate study-level incidence rates. Random-effects meta-analysis was used to pool results across studies.

RESULTS

Of 1123 records identified by the search, 20 studies (17 RCTs) and 8740 patients were included in the analysis. During 13 011 person-years of follow-up after discontinuing anticoagulation, the pooled incidence of major bleeding (n=41) and fatal bleeding (n=7) per 100 person-years was 0.35 (95% confidence interval [CI], 0.20-0.54) and 0.09 (95% CI, 0.05-0.15). The 5-year cumulative incidence of major bleeding was of 1.0% (95% CI, 0.4%-2.4%). The case-fatality rate of major bleeding after discontinuing anticoagulation was 19.9% (95% CI, 10.6%-31.1%).

CONCLUSIONS

Patients with a first unprovoked VTE have a non-trivial risk of major bleeding once anticoagulants are discontinued. Estimates from this study can help clinicians counsel patients about the incremental risk of major bleeding with extended anticoagulation to guide decision making about treatment duration for unprovoked VTE.
Date Issued
2022-07
Publication Type
Article
Language(s)
en
Author(s)
Khan, Faizan
Rahman, Alvi
Tritschler, Tobias  orcid-logo
Clinic of General Internal Medicine  
Clinic of General Internal Medicine  
Carrier, Marc
Kearon, Clive
Weitz, Jeffrey I
Schulman, Sam
Couturaud, Francis
Becattini, Cecilia
Agnelli, Giancarlo
Brighton, Timothy
Lensing, Anthonie Wa
Pinede, Laurent
Parpia, Sameer
Geersing, G J
Takada, Toshihiko
Bradbury, Charlotte
Andreozzi, Giuseppe Maria
Palareti, Gualtiero
Prandoni, Paolo
Buller, H R
Mallick, Ranjeeta
Hutton, Brian
Thavorn, Kednapa
Le Gal, Grégoire
Rodger, Marc
Fergusson, Dean A
Additional Credits
Clinic of General Internal Medicine  
Journal
Thrombosis and haemostasis
Publisher
Thieme
ISSN
2567-689X
Access(Rights)
restricted
Show full item
BORIS Portal
Bern Open Repository and Information System
Build: da6d1d [14.09. 16:14]
Explore
  • Projects
  • Funding
  • Publications
  • Research Data
  • Organizations
  • Researchers
  • Audiovisual Material
  • Software & other digital items
  • Events
More
  • About BORIS Portal
  • BORIS Portal & Open Science
  • Send Feedback
  • Cookie settings
  • Service Policy
Follow us on
  • Mastodon
  • YouTube
  • LinkedIn
UniBe logo
Repository logo COAR Notify